As a binding receptor of the PI3K/AKT pathway, GSK-3β exhibits serine/threonine kinase activity by phosphorylating various substrates that, in colon cancer cells, promote cell proliferation and increase gemcitabine chemoresistance [33]. The gene discussed is GSK3B; the disease is malignant colon neoplasm.